Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.

Item
http://www.wikidata.org/entity/Q33577450
Palliation of bone cancer pain by antagonists of platelet-activating factor receptorsA Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 K SNP-arrays and tumor histopathologyLysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cellsExpression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.Apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor.The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transition.Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapyEmerging targets for combination therapy in melanomas.Prognostic factors of clinical endpoints in elderly patients with atrial fibrillation during a 2-year follow-up in China: An observational cohort study.In vitro and in vivo antineoplastic and immunological effects of pterocarpanquinone LQB-118.β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling.Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of CD36 and platelet-activating factor receptor.Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor.
P2860

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.

Item
http://www.wikidata.org/entity/Q33577450
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Platelet-activating factor rec ...... mour response to chemotherapy.
@ast
Platelet-activating factor rec ...... mour response to chemotherapy.
@en
Platelet-activating factor receptor
@nl
type
label
Platelet-activating factor rec ...... mour response to chemotherapy.
@ast
Platelet-activating factor rec ...... mour response to chemotherapy.
@en
Platelet-activating factor receptor
@nl
prefLabel
Platelet-activating factor rec ...... mour response to chemotherapy.
@ast
Platelet-activating factor rec ...... mour response to chemotherapy.
@en
Platelet-activating factor receptor
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Platelet-activating factor rec ...... mour response to chemotherapy.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P921
P932